Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

BIO SUPPORTS NEW GUIDELINES TO ENSURE PATIENT CONFIDENCE IN GENE THERAPY TREATMENT
May 24 2000
(Michael J. Werner, Director of Federal Government Relations/Bioethics Counsel for the Biotechnology Industry Organization (BIO), issued the following...
BIO Selects DoubleTwist To Build Web Portal For Life Sciences Researchers, Companies
May 17 2000
WASHINGTON, D.C. and OAKLAND, Calif., May 17, 2000 The Biotechnology Industry Organization (BIO) and DoubleTwist Inc. today announced they signed a letter of...
BIO CEOs, Lawmakers Talk Policy At Legislative Day
May 15 2000
WASHINGTON, D.C., (May 15, 2000) - BIO anticipatesrecord-breaking attendance at its Legislative Day here Tuesday and Wednesday, May 16 - 17, with about 150...
BIO Says Maine Price Control Law Will Hurt Patients, Stifle Biotech Innovation
May 12 2000
WASHINGTON, D.C. (May 12, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a Maine...
BIO Supportive of FDA Announcement on Biotech Policies
May 3 2000
(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding FDA Commissioner Jane Henney’s...
XENOTRANSPLANTATION: The Benefits and Risks of Special Organ Transplantation
May 1 2000
A Position Paper fromThe Biotechnology Industry Organization Executive Summary 1. Human organ transplantation faces a significant challenge because the need...
BIO Testifies Proposed Rule On Confidentiality Of Patient Records Could Impede Research
Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Dr. Joanna C. Horobin, testifying on behalf of the Biotechnology Industry Organization (BIO), said today the Clinton...
Gorton Bill Will Result In Price Controls, Hurting Seniors, Not Helping Them
Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response to...
BIO Leads Coalition In Support Of Full Funding Of U.S. Patent Office
Apr 14 2000
WASHINGTON, D.C. (April 14, 2000) The BiotechnologyIndustry Organization (BIO) has put together a coalition of entrepreneurial associations to support full...
BIO Statement Regarding Congressional Report on the Safety of Agricultural Biotechnology
Apr 13 2000
WASHINGTON (APRIL 13, 2000)-- We commend the work of the House subcommittee report which encompasses the research and testimony of distinguished scientists who...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...